Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000403

Chief Financial Officer sold 10,991 shares at an average $307.95 ($3,384,680)

  • Chief Financial Officer acquired 10,991 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hippel James Chief Financial Officer 2020-11-09 Option exercise +3,600 $106.59 $383,724 12,737 D: show line 1 in the form
Hippel James Chief Financial Officer 2020-11-09 Sale −1,100 $306.81 $337,494 11,637 D: show line 2 in the form
Hippel James Chief Financial Officer 2020-11-09 Sale −100 $307.74 $30,774 11,537 D: show line 3 in the form
Hippel James Chief Financial Officer 2020-11-09 Sale −1,098 $310.55 $340,987 10,439 D: show line 4 in the form
Hippel James Chief Financial Officer 2020-11-09 Sale −1,002 $311.60 $312,221 9,437 D: show line 5 in the form
Hippel James Chief Financial Officer 2020-11-09 Sale −300 $312.58 $93,775 9,137 D: show line 6 in the form
Hippel James Chief Financial Officer 2020-11-11 Option exercise +7,391 $106.59 $787,807 16,528 D: show line 7 in the form
Hippel James Chief Financial Officer 2020-11-11 Sale −6,291 $306.93 $1,930,874 10,237 D: show line 8 in the form
Hippel James Chief Financial Officer 2020-11-11 Sale −1,100 $307.78 $338,555 9,137 D: show line 9 in the form
Open-market sales · 10,991 sh · avg $307.95 · $3,384,680

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hippel James Chief Financial Officer 2020-11-09 Option exercise · Stock Options (Right to Buy) −3,600 67,333 D: show line 10 in the form
Hippel James Chief Financial Officer 2020-11-11 Option exercise · Stock Option (Right to Buy) −9,137 58,196 D: show line 11 in the form
Loading xslF345X03/edgar.xml…